India’s E-Pharmacy Sector Urges Government for Clearer, Fairer Regulations

New Delhi:  Industry leaders, policy experts, and entrepreneurs from India’s digital healthcare sector have urged the government to frame a balanced regulatory framework for e-pharmacies, highlighting their role in expanding healthcare access across the country.

The discussion took place during a webinar organised by CUTS International, moderated by senior journalist Anil Padmanabhan.

Speakers noted that e-pharmacies already serve over 15,000 pin codes, reaching patients in remote towns and villages with limited physical pharmacy access.

They emphasized that technology-enabled features like prescription validation, drug authentication, and traceability often ensure higher safety standards compared to offline pharmacies.

According to Bipul Chattopadhyay, Executive Director of CUTS International, e-pharmacies offer more than just affordable pricing.

With 24/7 availability, doorstep delivery, refill reminders, and access to online consultations, they have transformed consumer experience in healthcare.

Panelists stressed the urgent need for clear regulations to ensure patient safety while enabling innovation. Nirupama Soundararajan, Co-founder & CEO of Policy Consensus Centre, said pharmacies cannot operate in a regulatory vacuum, particularly given the sensitive nature of medicines.

Legal and public health experts added that e-pharmacies must be regulated by the national drug authority and Ministry of Health to ensure quality control and storage compliance.

Centralized warehouses, they argued, give regulators an opportunity to enforce stricter standards, though risks of misuse remain in both offline and online markets.

The discussion underlined that e-pharmacies should complement, not replace, traditional chemists. Examples were cited of local pharmacies expanding their reach by integrating with digital platforms.

Experts predicted that the future of pharmacies in India would follow an omnichannel model, combining local chemists, branded chains, and online platforms.

The session concluded with a call for regulatory clarity on prescription protocols, data security, and operational norms, ensuring that patients benefit from safe, accessible, and transparent healthcare services.

Related Posts

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week. Argentina has committed to reduce barriers to facilitate the entry of…

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

The regulator had found that medicines were stored directly on the floor and flagged deficiencies in procedures for handling expired medicines.   The Maharashtra Food and Drug Administration has cancelled…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

Six fake doctors arrested in Hyderabad

Six fake doctors arrested in Hyderabad